Associated Papers
Circulating Tumor Cell-Free DNA as Prognostic Biomarker in Non-Small Cell Lung Cancer Patients Undergoing Immunotherapy: The CORELAB Experience.
Gelmini S et al.
International Journal of Molecular Sciences, 2025
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.
Chamorro DF et al.
Targeted Oncology, 2023
37017806 (PubMed )
Supplement: 11523_2023_955_MOESM1_ESM.pdf
Pan-cancer analysis of CD274 (PD-L1) mutations in 314,631 patient samples and subset correlation with PD-L1 protein expression.
Huang RSP et al.
Journal for Immunotherapy of Cancer, 2021
Select a paper to view details